Literature DB >> 25292025

Exercise barriers in Korean colorectal cancer patients.

Dong-Woo Kang1, Jae Youn Chung, Mi Kyung Lee, Junga Lee, Ji-Hye Park, Dong-Il Kim, Lee W Jones, Joong Bae Ahn, Nam Kyu Kim, Justin Y Jeon.   

Abstract

BACKGROUND: To identify barriers to exercise in Korean colorectal cancer patients and survivors, and to analyze differences in exercise barriers by age, gender, treatment status, and physical activity level.
MATERIALS AND METHODS: A total of 427 colorectal cancer patients and survivors from different stages and medical status completed a self-administered questionnaire that surveyed their barriers to exercise and exercise participation.
RESULTS: The greatest perceived exercise barriers for the sampled population as a whole were fatigue, low level of physical fitness, and poor health. Those under 60-years old reported lack of time (p=0.008), whereas those over 60 reported low level of physical fitness (p=0.014) as greater exercise barriers than their counterparts. Women reported fatigue as a greater barrier than men (p<0.001). Those who were receiving treatment rated poor health (p=0.0005) and cancer-related factors as greater exercise barriers compared to those who were not receiving treatment. A multivariate model found that other demographic and medical status were not potential factors that may affect exercise participation. Further, for those who were not participating in physical activity, tendency to be physically inactive (p<0.001) and lack of exercise skill (p<0.001) were highly significant barriers, compared to those who were participating in physical activity. Also, for those who were not meeting ACSM guidelines, cancer-related exercise barriers were additionally reported (p<0.001), compared to those who were.
CONCLUSIONS: Our study suggests that fatigue, low level of physical fitness, and poor health are most reported exercise barriers for Korean colorectal cancer survivors and there are differences in exercise barriers by age, sex, treatment status, and physical activity level. Therefore, support for cancer patients should be provided considering these variables to increase exercise participation.

Entities:  

Mesh:

Year:  2014        PMID: 25292025     DOI: 10.7314/apjcp.2014.15.18.7539

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Associations between physical activity and comorbidities in Korean cancer survivors.

Authors:  Dong-Woo Kang; Eun-Young Lee; Ki Yong An; Jihee Min; Justin Y Jeon; Kerry S Courneya
Journal:  J Cancer Surviv       Date:  2018-03-01       Impact factor: 4.442

2.  The association of physical activity and colorectal and breast cancer: The Fifth Korea National Health and Nutrition Examination Survey (2008-2011).

Authors:  Suh-Jung Kang
Journal:  J Exerc Rehabil       Date:  2015-06-30

3.  Barriers and facilitators to exercise among adult cancer survivors in Singapore.

Authors:  Alexandre Chan; Kayleen Ports; Patricia Neo; Mothi Babu Ramalingam; Ang Tee Lim; Benedict Tan; Nicolas H Hart; Raymond J Chan; Kiley Loh
Journal:  Support Care Cancer       Date:  2022-02-14       Impact factor: 3.359

Review 4.  Implementation barriers to integrating exercise as medicine in oncology: an ecological scoping review.

Authors:  Mary A Kennedy; Sara Bayes; Robert U Newton; Yvonne Zissiadis; Nigel A Spry; Dennis R Taaffe; Nicolas H Hart; Daniel A Galvão
Journal:  J Cancer Surviv       Date:  2021-09-12       Impact factor: 4.062

5.  Effects of supervised high-intensity interval training on motivational outcomes in men with prostate cancer undergoing active surveillance: results from a randomized controlled trial.

Authors:  Dong-Woo Kang; Normand G Boulé; Catherine J Field; Adrian S Fairey; Kerry S Courneya
Journal:  Int J Behav Nutr Phys Act       Date:  2022-09-29       Impact factor: 8.915

6.  Effect of the 6-week home-based exercise program on physical activity level and physical fitness in colorectal cancer survivors: A randomized controlled pilot study.

Authors:  Mi Kyung Lee; Nam Kyu Kim; Justin Y Jeon
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.